See more : Ya Horng Electronic Co., Ltd. (6201.TW) Income Statement Analysis – Financial Results
Complete financial analysis of Roche Holding AG (0QQ6.L) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Roche Holding AG, a leading company in the Drug Manufacturers – General industry within the Healthcare sector.
- Euromax Resources Ltd. (EOX.TO) Income Statement Analysis – Financial Results
- Orsero S.p.A. (ORS.MI) Income Statement Analysis – Financial Results
- Xiangyang BOYA Precision Industrial Equipments Co., Ltd (300971.SZ) Income Statement Analysis – Financial Results
- SharpSpring, Inc. (SHSP) Income Statement Analysis – Financial Results
- Nobel Resources Corp. (NBLC.V) Income Statement Analysis – Financial Results
Roche Holding AG (0QQ6.L)
About Roche Holding AG
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, Austria, Netherlands, the United Kingdom, France, Belgium, and internationally. The company offers pharmaceutical products for treating oncology, neuroscience, infectious, immunology, cardiovascular and metabolism, ophthalmology, and respiratory, as well as anemia, cancer, dermatology, hemophilia, inflammatory and autoimmune, neurological, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD). The company was founded in 1896 and is headquartered in Basel, Switzerland.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 60.44B | 63.28B | 62.80B | 58.32B | 63.75B | 59.50B | 55.75B | 52.64B | 50.40B | 49.87B | 48.61B | 45.50B | 42.53B | 47.47B | 49.05B | 45.62B | 46.13B | 42.04B | 35.51B | 31.27B | 31.22B | 29.73B | 29.16B | 28.67B | 27.57B | 24.66B |
Cost of Revenue | 16.36B | 18.84B | 19.70B | 16.35B | 17.39B | 16.52B | 15.89B | 15.08B | 14.25B | 12.98B | 12.38B | 12.18B | 11.94B | 13.29B | 14.62B | 13.66B | 13.74B | 10.62B | 9.30B | 7.18B | 8.32B | 8.43B | 8.34B | 9.16B | 8.87B | 7.90B |
Gross Profit | 44.08B | 44.44B | 43.10B | 41.97B | 46.37B | 42.98B | 39.86B | 37.56B | 36.16B | 36.89B | 36.23B | 33.32B | 30.59B | 34.18B | 34.44B | 31.96B | 32.39B | 31.43B | 26.21B | 24.09B | 22.91B | 21.29B | 20.82B | 19.51B | 18.69B | 16.76B |
Gross Profit Ratio | 72.94% | 70.23% | 68.63% | 71.96% | 72.73% | 72.23% | 71.50% | 71.35% | 71.74% | 73.97% | 74.54% | 73.24% | 71.92% | 72.00% | 70.20% | 70.05% | 70.21% | 74.75% | 73.80% | 77.03% | 73.37% | 71.63% | 71.41% | 68.04% | 67.81% | 67.96% |
Research & Development | 14.20B | 14.05B | 13.71B | 12.15B | 12.77B | 12.09B | 11.29B | 11.53B | 9.58B | 9.90B | 9.27B | 9.55B | 8.33B | 10.03B | 9.87B | 8.85B | 8.39B | 6.59B | 5.71B | 5.09B | 4.77B | 4.26B | 3.89B | 3.95B | 3.78B | 3.41B |
General & Administrative | 14.88B | 14.20B | 2.43B | 2.46B | 2.49B | 2.59B | 2.36B | 1.15B | 2.15B | 2.21B | 2.11B | 3.05B | 2.34B | 2.87B | 2.18B | 2.33B | 2.45B | 2.54B | 11.91B | 10.41B | 10.30B | 9.83B | 9.67B | 9.99B | 8.99B | 7.83B |
Selling & Marketing | 0.00 | 9.64B | 9.48B | 9.39B | 10.55B | 9.94B | 9.52B | 9.01B | 8.61B | 8.44B | 8.25B | 8.54B | 8.05B | 9.49B | 9.48B | 9.17B | 9.33B | 10.86B | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
SG&A | 14.88B | 12.03B | 11.87B | 11.82B | 13.18B | 12.67B | 12.03B | 10.34B | 10.94B | 10.84B | 10.59B | 11.59B | 10.39B | 12.36B | 11.65B | 11.50B | 11.78B | 13.40B | 11.91B | 10.41B | 10.30B | 9.83B | 9.67B | 9.99B | 8.99B | 7.83B |
Other Expenses | -392.00M | -192.00M | -238.00M | -265.00M | -227.00M | -197.00M | -311.00M | -316.00M | 0.00 | 0.00 | 0.00 | -1.93B | -1.57B | -1.67B | -2.08B | -2.29B | -2.24B | -277.00M | -80.00M | -389.00M | 2.25B | 5.87B | 4.01B | -1.56B | -497.00M | 1.16B |
Operating Expenses | 28.69B | 26.27B | 25.82B | 24.24B | 29.23B | 28.26B | 27.04B | 23.87B | 23.31B | 23.46B | 20.50B | 19.21B | 17.15B | 20.71B | 19.45B | 18.06B | 17.92B | 19.71B | 17.54B | 15.11B | 17.31B | 19.96B | 17.58B | 12.38B | 12.27B | 12.39B |
Cost & Expenses | 45.05B | 45.11B | 45.52B | 40.59B | 46.62B | 44.78B | 42.93B | 38.95B | 37.56B | 36.44B | 32.88B | 31.39B | 29.09B | 34.01B | 34.06B | 31.72B | 31.67B | 30.33B | 26.84B | 22.29B | 25.63B | 28.39B | 25.92B | 21.54B | 21.15B | 20.29B |
Interest Income | 195.00M | 568.00M | 342.00M | 16.00M | 520.00M | 574.00M | 566.00M | 683.00M | 859.00M | 909.00M | 1.06B | 32.00M | 73.00M | 51.00M | 179.00M | 698.00M | 1.07B | 788.00M | 423.00M | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Expense | 997.00M | 608.00M | 341.00M | 438.00M | 620.00M | 605.00M | 598.00M | 707.00M | 1.11B | 1.18B | 1.33B | 2.00B | 2.01B | 2.55B | 2.44B | 214.00M | 281.00M | 315.00M | 326.00M | 0.00 | 1.08B | 4.52B | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 3.46B | 3.82B | 4.45B | 4.57B | 4.31B | 3.60B | 3.89B | 3.95B | 3.59B | 2.62B | 2.38B | 2.42B | 2.37B | 2.55B | 2.69B | 2.65B | 2.54B | 2.44B | 1.01B | 1.61B | 1.51B | 1.52B | 1.55B | 2.85B | 2.45B | 2.07B |
EBITDA | 18.41B | 20.80B | 22.19B | 22.97B | 21.56B | 18.34B | 16.74B | 17.67B | 19.05B | 19.13B | 18.15B | 16.01B | 15.72B | 15.66B | 14.71B | 17.02B | 18.13B | 15.38B | 11.80B | 10.58B | 7.10B | 2.86B | 4.80B | 27.57B | 8.87B | 6.44B |
EBITDA Ratio | 30.46% | 34.76% | 34.60% | 38.23% | 39.17% | 37.83% | 38.00% | 39.25% | 37.79% | 38.37% | 39.06% | 37.30% | 38.48% | 34.69% | 37.52% | 36.12% | 37.31% | 33.97% | 27.26% | 33.84% | 22.75% | 9.60% | 16.46% | 34.80% | 32.19% | 26.13% |
Operating Income | 15.40B | 18.18B | 17.28B | 17.73B | 21.03B | 18.92B | 17.30B | 16.85B | 15.46B | 16.51B | 16.61B | 14.13B | 13.45B | 13.49B | 12.28B | 13.92B | 14.47B | 11.73B | 8.67B | 8.98B | 5.59B | 1.34B | 3.25B | 7.13B | 6.42B | 4.37B |
Operating Income Ratio | 25.47% | 28.72% | 27.52% | 30.40% | 32.99% | 31.80% | 31.03% | 32.01% | 30.67% | 33.11% | 34.17% | 31.04% | 31.63% | 28.41% | 25.03% | 30.52% | 31.36% | 27.90% | 24.41% | 28.71% | 17.91% | 4.49% | 11.13% | 24.87% | 23.29% | 17.72% |
Total Other Income/Expenses | -1.32B | -1.11B | 117.00M | -577.00M | -934.00M | -621.00M | -755.00M | -1.06B | -1.83B | -1.58B | -1.70B | -1.80B | -1.57B | -2.28B | -2.05B | 236.00M | 836.00M | 857.00M | 133.00M | 4.25B | -711.00M | -4.53B | 1.52B | 2.34B | 1.13B | 1.08B |
Income Before Tax | 14.08B | 16.37B | 17.40B | 17.97B | 16.61B | 14.15B | 12.25B | 13.01B | 11.99B | 12.52B | 14.68B | 12.32B | 11.89B | 11.21B | 10.23B | 14.16B | 15.30B | 12.59B | 8.97B | 9.49B | 4.88B | -3.19B | 4.76B | 9.47B | 7.56B | 5.45B |
Income Before Tax Ratio | 23.29% | 25.87% | 27.71% | 30.80% | 26.06% | 23.78% | 21.97% | 24.71% | 23.78% | 25.10% | 30.19% | 27.08% | 27.94% | 23.62% | 20.86% | 31.04% | 33.17% | 29.94% | 25.25% | 30.33% | 15.63% | -10.75% | 16.33% | 33.02% | 27.41% | 22.11% |
Income Tax Expense | 1.72B | 2.80B | 2.46B | 2.90B | 2.51B | 3.28B | 3.42B | 3.27B | 2.93B | 2.98B | 3.30B | 2.55B | 2.34B | 2.32B | 1.72B | 3.32B | 3.87B | 3.44B | 2.22B | 2.35B | 1.45B | 839.00M | 1.04B | 2.27B | 1.90B | 965.00M |
Net Income | 11.50B | 12.42B | 13.93B | 14.30B | 13.50B | 10.50B | 8.63B | 9.58B | 8.86B | 9.33B | 11.16B | 9.54B | 9.34B | 8.67B | 7.78B | 8.97B | 9.76B | 7.88B | 6.73B | 6.64B | 3.07B | -4.03B | 3.70B | 8.65B | 5.76B | 4.39B |
Net Income Ratio | 19.02% | 19.63% | 22.18% | 24.51% | 21.17% | 17.65% | 15.49% | 18.19% | 17.58% | 18.71% | 22.97% | 20.97% | 21.97% | 18.25% | 15.87% | 19.66% | 21.16% | 18.74% | 18.95% | 21.24% | 9.83% | -13.54% | 12.68% | 30.16% | 20.91% | 17.81% |
EPS | 14.39 | 15.53 | 16.39 | 16.72 | 15.77 | 12.30 | 10.12 | 11.24 | 10.41 | 10.99 | 13.17 | 11.12 | 11.01 | 10.14 | 9.07 | 10.43 | 11.36 | 9.24 | 7.01 | 7.86 | 3.66 | -4.80 | 4.40 | 10.29 | 6.68 | 5.09 |
EPS Diluted | 14.30 | 15.53 | 16.20 | 16.52 | 15.62 | 12.21 | 10.04 | 11.13 | 10.28 | 10.81 | 12.94 | 11.03 | 10.98 | 10.11 | 9.02 | 10.23 | 11.16 | 9.05 | 6.87 | 7.77 | 3.61 | -4.80 | 4.37 | 10.24 | 6.68 | 5.09 |
Weighted Avg Shares Out | 799.00M | 800.00M | 850.00M | 855.00M | 856.00M | 854.00M | 853.00M | 852.00M | 851.00M | 849.00M | 848.00M | 848.00M | 849.00M | 855.00M | 858.00M | 860.00M | 859.00M | 852.00M | 845.00M | 840.46M | 839.00M | 838.75M | 840.23M | 840.23M | 862.87M | 862.87M |
Weighted Avg Shares Out (Dil) | 804.00M | 800.00M | 860.00M | 865.00M | 864.00M | 860.00M | 860.00M | 860.00M | 862.00M | 863.00M | 863.00M | 855.00M | 851.00M | 857.00M | 859.00M | 861.00M | 862.00M | 862.00M | 860.00M | 850.19M | 850.14M | 838.75M | 862.87M | 844.43M | 862.87M | 862.87M |
Source: https://incomestatements.info
Category: Stock Reports